About Venlafaxine - NHS

Overview

Venlafaxine is an antidepressant in the group known as serotonin and noradrenaline reuptake inhibitors (SNRIs).
It functions by increasing serotonin and noradrenaline levels in the brain, chemicals that enhance mood.
Primarily used to treat depression, and also sometimes used for anxiety and panic attacks.
Known for helping people recover from depression with fewer side effects compared to older antidepressants.
Available in tablet and capsule form, but only with a prescription.

Effectiveness: Takes about 4 to 6 weeks to work fully; initial improvement may be felt in 1 to 2 weeks.
Common Side Effects: Include nausea, headaches, sweating, and dry mouth. Generally mild and disappear after a few weeks.
Withdrawal: If stopping venlafaxine, the dose should be reduced gradually under doctor’s guidance to avoid withdrawal symptoms.
Cardiovascular Effects: Can increase heart rate or lead to an irregular heartbeat (arrhythmia); caution recommended for those on heart medication.
Impact on Personality: Does not alter personality; helps patients feel like themselves again.

Resources Available: More information on who can take it, dosage instructions, side effects, effects on pregnancy, interactions with other medicines, and FAQs are available on the NHS website.
Review Cycle: Last reviewed on 10 February 2022, with the next review due on 10 February 2025.

Links to NHS resources such as Health A to Z, Mental Health support, and NHS services are provided for further assistance and information.
Additional support includes access to the NHS App, finding NHS numbers, and viewing health records and test results online.

For a more comprehensive understanding, explore further on the NHS website links provided in the document.